Skip to content
zameds

No structure available

This product's active ingredient could not be matched to a single known compound.

Registration

Applicants
1
Registrations
4

Applicants and registrations

ApplicantBrandsDosagesRegistrationsScheduleLeaflets
Hetero Drugs South Africa (Pty) LtdHatosat10 mg, 20 mg, 40 mg, 80 mg570899.895, 570900.896, 570901.897, 570902.898Not determinedNone

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Hatosat 10 MG

EACH TABLET CONTAINS: ATORVASTATIN CALCIUM TRIHYDRATE EQUIVALENT TO ATORVASTATIN 10,0 mg

10 mg570899.89557/7.5/0899.895RegisteredNot determinedNone
Hatosat 20 MG

EACH TABLET CONTAINS: ATORVASTATIN CALCIUM TRIHYDRATE EQUIVALENT TO ATORVASTATIN 20,0 mg

20 mg570900.89657/7.5/0900.896RegisteredNot determinedNone
Hatosat 40 MG

EACH TABLET CONTAINS: ATORVASTATIN CALCIUM TRIHYDRATE EQUIVALENT TO ATORVASTATIN 40,0 mg

40 mg570901.89757/7.5/0901.897RegisteredNot determinedNone
Hatosat 80 MG

EACH TABLET CONTAINS: ATORVASTATIN CALCIUM TRIHYDRATE EQUIVALENT TO ATORVASTATIN 80,0 mg

80 mg570902.89857/7.5/0902.898RegisteredNot determinedNone

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

Background

Loading...
Loading Wikipedia summary

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Research articles

Loading...
Loading PubMed articles